Detection of human papillomaviruses in cervical neoplasias using multiple sets of generic polymerase chain reaction primers

被引:31
作者
Kado, S
Kawamata, Y
Shino, Y
Kasai, T
Kubota, K
Iwasaki, H
Fukazawa, I
Takano, H
Nunoyama, T
Mitsuhashi, A
Sekiya, S
Shirasawa, H
机构
[1] Chiba Univ, Dept Mol Virol, Chuo Ku, Chiba 260, Japan
[2] Chiba Univ, Sch Med, Dept Obstet & Gynecol, Chuo Ku, Chiba 260, Japan
关键词
human papillomavirus; cervical neoplasia; polymerase chain reaction; primer;
D O I
10.1006/gyno.2000.6116
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. The aim of this study was to evaluate precisely the differences in the spectra of human papillomavirus (HPV) types detected by different generic primer pairs commonly used for detection of this extraordinarily heterogeneous virus. Methods. Three sets of polymerase chain reaction (PCR) primers for the L1 open reading frame (ORF) and two sets for E6/E7 ORFs were used to detect HPVs in DNAs from 107 cervical tissues, including 77 cervical neoplasias. HPV types were determined by analysis of restriction fragment length polymorphisms (RFLPs) and nucleotide sequencing. Results. A high overall detection rate of HPV in cervical neoplasias (76/77, 98.7%) was achieved by polymerase chain reaction (PCR) amplification with multiple sets of generic primers, while the detection rate for each individual primer pair varied from 48/77 (62%) to 70/77 (91%). Only in 34 of 77 cases (44%) were HPV DNAs positive for all sets of primer pairs. Further determination of HPV types by RFLPs and nucleotide sequencing showed inconsistencies between the PCR primer pairs used. Conclusion. Our study revealed that the HPV detection rate is critically affected by the choice of PCR primers, and that appropriate use of combinations of generic PCR primer sets followed by RFLP analyses is both necessary and sufficient for typing most HPVs in cervical lesions. More precise methods such as sequencing would be necessary in only a few cases. (C) 2001 Academic Press.
引用
收藏
页码:47 / 52
页数:6
相关论文
共 18 条
  • [1] Characterization of a putative new HPV genomic sequence from a cervical lesion using L1 consensus primers and restriction fragment length polymorphism
    Astori, G
    Arzese, A
    Pipan, C
    deVilliers, EM
    Botta, GA
    [J]. VIRUS RESEARCH, 1997, 50 (01) : 57 - 63
  • [2] IDENTIFICATION AND ASSESSMENT OF KNOWN AND NOVEL HUMAN PAPILLOMAVIRUSES BY POLYMERASE CHAIN-REACTION AMPLIFICATION, RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISMS, NUCLEOTIDE-SEQUENCE, AND PHYLOGENETIC ALGORITHMS
    BERNARD, HU
    CHAN, SY
    MANOS, MM
    ONG, CK
    VILLA, LL
    DELIUS, H
    PEYTON, CL
    BAUER, HM
    WHEELER, CM
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (05) : 1077 - 1085
  • [3] THE HUMAN PAPILLOMA VIRUS-16 E7-ONCOPROTEIN IS ABLE TO BIND TO THE RETINOBLASTOMA GENE-PRODUCT
    DYSON, N
    HOWLEY, PM
    MUNGER, K
    HARLOW, E
    [J]. SCIENCE, 1989, 243 (4893) : 934 - 937
  • [4] SIMULTANEOUS DETECTION AND TYPING OF GENITAL HUMAN PAPILLOMAVIRUS DNA USING THE POLYMERASE CHAIN-REACTION
    FUJINAGA, Y
    SHIMADA, M
    OKAZAWA, K
    FUKUSHIMA, M
    KATO, I
    FUJINAGA, K
    [J]. JOURNAL OF GENERAL VIROLOGY, 1991, 72 : 1039 - 1044
  • [5] Use of multiple PCR primer sets for optimal detection of human papillomavirus
    Karlsen, F
    Kalantari, M
    Jenkins, A
    Pettersen, E
    Kristensen, G
    Holm, R
    Johansson, B
    Hagmar, B
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (09) : 2095 - 2100
  • [6] HUMAN PAPILLOMAVIRUS INFECTION OF THE CERVIX - RELATIVE RISK ASSOCIATIONS OF 15 COMMON ANOGENITAL TYPES
    LORINCZ, AT
    REID, R
    JENSON, AB
    GREENBERG, MD
    LANCASTER, W
    KURMAN, RJ
    [J]. OBSTETRICS AND GYNECOLOGY, 1992, 79 (03) : 328 - 337
  • [7] MANOS MM, 1989, CANCER CEL, V7, P209
  • [8] IDENTIFICATION OF GENITAL HUMAN PAPILLOMAVIRUSES IN CERVICAL BIOPSY SPECIMENS - SEGREGATION OF SPECIFIC VIRUS TYPES IN SPECIFIC CLINICOPATHOLOGICAL LESIONS
    MATSUKURA, T
    SUGASE, M
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1995, 61 (01) : 13 - 22
  • [9] THE E6 ONCOPROTEIN ENCODED BY HUMAN PAPILLOMAVIRUS TYPE-16 AND TYPE-18 PROMOTES THE DEGRADATION OF P53
    SCHEFFNER, M
    WERNESS, BA
    HUIBREGTSE, JM
    LEVINE, AJ
    HOWLEY, PM
    [J]. CELL, 1990, 63 (06) : 1129 - 1136
  • [10] EPIDEMIOLOGIC EVIDENCE SHOWING THAT HUMAN PAPILLOMAVIRUS INFECTION CAUSES MOST CERVICAL INTRAEPITHELIAL NEOPLASIA
    SCHIFFMAN, MH
    BAUER, HM
    HOOVER, RN
    GLASS, AG
    CADELL, DM
    RUSH, BB
    SCOTT, DR
    SHERMAN, ME
    KURMAN, RJ
    WACHOLDER, S
    STANTON, CK
    MANOS, MM
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (12): : 958 - 964